Medico Intercontinental Ltd

Medico Intercontinental Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

For the fourth consecutive session, Medico Intercontinental Ltd has declined, culminating in a fresh 52-week low of Rs 20.61 on 2 Jun 2026. This marks a near 50% drop over the past year, significantly underperforming the broader Sensex, which itself is hovering close to its own 52-week low.

Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has seen a marked deterioration in its valuation parameters, prompting a downgrade to a Strong Sell rating. With its price-to-earnings ratio plunging into negative territory and price-to-book value remaining low, the stock’s price attractiveness has shifted from very expensive to risky, signalling caution for investors amid sustained underperformance against benchmark indices.

Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended March 2026, signalling a pause in its previously negative trend. Despite achieving its highest quarterly net sales at ₹22.49 crores, the company continues to grapple with elevated debt levels and a deteriorating stock price, reflecting ongoing challenges in its operational and market positioning.

Medico Intercontinental Limited, a micro-cap pharmaceutical trading company, reported a consolidated net loss of ₹0.65 crores for Q4 FY26, marking a dramatic reversal from the ₹1.17 crores profit recorded in the same quarter last year. The 155.56% year-on-year decline and 195.45% quarter-on-quarter deterioration signal deepening operational distress that has persisted throughout FY26. With a market capitalisation of just ₹23.00 crores and the stock trading at ₹21.59—down 5.6% on the day—investor confidence appears to be evaporating rapidly.

For the fifth consecutive session, Medico Intercontinental Ltd closed lower, hitting a fresh 52-week low of Rs 20.81 on 22 May 2026, marking a steep decline of 48.32% over the past year amid persistent selling pressure.

A sharp decline has pushed Medico Intercontinental Ltd to a fresh 52-week low of Rs 21.06 on 13 May 2026, marking a 43.51% drop over the past year and signalling sustained pressure on the micro-cap stock amid broader market weakness.

For the second consecutive session, Medico Intercontinental Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 21.58 on 12 May 2026. This latest drop extends the stock’s year-long slide, which now stands at a steep 42.23% loss, significantly underperforming the broader Sensex’s 8.57% decline over the same period.

Medico Intercontinental Ltd’s stock price declined to a fresh 52-week low of Rs.22.5 on 6 May 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and benchmark indices amid deteriorating financial metrics and persistent negative quarterly results.

For the fifth consecutive session, Medico Intercontinental Ltd closed lower, slipping to a fresh 52-week low of Rs 23 on 5 May 2026. This decline comes despite a modest outperformance relative to its sector today, highlighting persistent pressure on the stock amid broader market weakness.

For the second consecutive session, Medico Intercontinental Ltd has extended its decline, hitting a fresh 52-week low of Rs 23.5 on 4 May 2026. This latest drop comes amid a broader underperformance relative to its sector and the benchmark indices, signalling sustained selling pressure on the micro-cap stock.

A sustained decline has pushed Medico Intercontinental Ltd to a fresh 52-week low of Rs 23.75 on 30 Apr 2026, marking a 35.72% drop over the past year and underscoring persistent headwinds despite some pockets of operational resilience.

Medico Intercontinental Ltd’s share price declined sharply to a new 52-week low of Rs.23.85 on 28 April 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock’s performance has been notably weak over the past year, reflecting a combination of deteriorating financial metrics and persistent market pressures.

For the fifth consecutive session, Medico Intercontinental Ltd has closed lower, slipping to a fresh 52-week low of Rs 24.61 on 27 Apr 2026. This decline comes amid a broader market rally, underscoring the stock's persistent underperformance relative to its peers and benchmark indices.

Medico Intercontinental Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 16 April 2026, providing investors with the latest insights into its performance and valuation.